PHARMACYCLICS INC's ticker is PCYC and the CUSIP is 716933106. A total of 280 filers reported holding PHARMACYCLICS INC in Q1 2014. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,062,000 | -15.6% | 4,149 | -59.7% | 0.02% | +4.8% |
| Q4 2014 | $1,258,000 | +17.1% | 10,290 | +12.5% | 0.02% | 0.0% |
| Q3 2014 | $1,074,000 | +48.3% | 9,145 | +13.3% | 0.02% | +90.9% |
| Q2 2014 | $724,000 | -54.9% | 8,070 | -49.6% | 0.01% | -45.0% |
| Q1 2014 | $1,604,000 | +33.6% | 16,011 | +41.0% | 0.02% | +53.8% |
| Q4 2013 | $1,201,000 | +30.7% | 11,355 | +71.0% | 0.01% | +8.3% |
| Q3 2013 | $919,000 | – | 6,639 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 9,129,231 | $1,116,140,000 | 11.39% |
| DAFNA Capital Management LLC | 110,928 | $13,562,000 | 10.73% |
| HWG Holdings LP | 107,389 | $13,129,000 | 9.36% |
| Opaleye Management Inc. | 85,000 | $10,392,000 | 5.25% |
| Opus Point Partners Management, LLC | 25,723 | $3,145,000 | 3.11% |
| BB BIOTECH AG | 731,542 | $89,438,000 | 2.90% |
| Peregrine Asset Advisers, Inc. | 33,375 | $4,080,000 | 2.87% |
| HARVEY CAPITAL MANAGEMENT INC | 54,770 | $6,696,000 | 2.57% |
| Parametric Risk Advisors LLC | 300,000 | $36,678,000 | 2.45% |
| BENDER ROBERT & ASSOCIATES | 28,619 | $3,499,000 | 2.29% |